Breaking News Instant updates and real-time market news.

2020-11-30 10:45:02 ATVI Activision Blizzard $78.98 / +0.84 (+1.07%) 10:45 11/30/20 11/30 10:45 11/30/20 10:45	Activision Blizzard call volume above normal and directionally bullish Bullish option flow detected in Activision Blizzard with 15,595 calls trading, 2.0x expected, and implied vol increasing almost 2 points to 31.33%. Apr-21 85 calls and 12/4 weekly 80 calls are the most active options, with total volume in those strikes near 6,200 contracts. The Put/Call Ratio is 0.15. Earnings are expected on February 2nd.	01 Dec 07 Dec
ATVI Activision Blizzard $78.98 / +0.84 (+1.07%) 11/20/20 KeyBanc No midweek PR suggests 'weak' opening sales for new 'Call of Duty,' says KeyBanc 11/11/20 Truist Electronic Arts price target lowered to $138 from $153 at Truist 10/30/20 Benchmark Activision Blizzard price target raised to $109 from $102 at Benchmark 10/30/20 KeyBanc Activision Blizzard price target raised to $102 from $96 at KeyBanc

2020-11-30 10:45:02

ATVI

Activision Blizzard

$78.98 / +0.84 (+1.07%)

10:45

11/30/20

11/30

10:45

11/30/20

10:45

Activision Blizzard call volume above normal and directionally bullish

Bullish option flow detected in Activision Blizzard with 15,595 calls trading, 2.0x expected, and implied vol increasing almost 2 points to 31.33%. Apr-21 85 calls and 12/4 weekly 80 calls are the most active options, with total volume in those strikes near 6,200 contracts. The Put/Call Ratio is 0.15. Earnings are expected on February 2nd.

01
Dec
07
Dec

ATVI Activision Blizzard

$78.98 / +0.84 (+1.07%)

11/20/20 KeyBanc: No midweek PR suggests 'weak' opening sales for new 'Call of Duty,' says KeyBanc

11/11/20 Truist: Electronic Arts price target lowered to $138 from $153 at Truist

10/30/20 Benchmark: Activision Blizzard price target raised to $109 from $102 at Benchmark

10/30/20 KeyBanc: Activision Blizzard price target raised to $102 from $96 at KeyBanc

TODAY'S FREE FLY STORIES

Technical Analysis	NASDAQ market internals summary » 13:17 01/22/21 01/22 13:17 01/22/21 13:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 01/21/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 01/22/21 01/22 13:16 01/22/21 13:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 01/21/21 NYSE market internals summary
Hot Stocks	Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO » 13:12 01/22/21 01/22 13:12 01/22/21 13:12 EXEL Exelixis $21.63 / +0.3 (+1.41%) Exelixis announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EXEL Exelixis $21.63 / +0.3 (+1.41%) 12/21/20 Exelixis announces cabozantinib trial meets co-primary endpoint 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/02/20 Exelixis exercises option for Iconic's ADC, to develop under May 2019 pact EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 12/14/20 William Blair Calithera risk/reward attractive into CANTATA readout, says William Blair 10/26/20 Piper Sandler Exelixis could have successor to Cabometyx with XL092, says Piper Sandler 09/22/20 Morgan Stanley Exelixis price target raised to $29 from $23 at Morgan Stanley EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/10/21 Exelixis sees FY21 revenue $1.15B-$1.25B, consensus $1.16B 01/10/21 Exelixis reports preliminary Q4 revenue $270M, consensus $213.78M 11/05/20 Exelixis sees FY20 revenue $900M-$950M, consensus $922M 11/05/20 Exelixis reports Q3 adjusted EPS 4c, consensus 1c 03/01/21 41st Annual Healthcare Virtual Conference 02/20/21 PDUFA Date for OPDIVO / CABOMETYX bmy
Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs » 13:11 01/22/21 01/22 13:11 01/22/21 13:11 BKR Baker Hughes $22.15 / -0.41 (-1.82%) Baker Hughes reports that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $22.15 / -0.41 (-1.82%) 13:01 Today Baker Hughes reports U.S. rig count up 5 to 378 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $22.15 / -0.41 (-1.82%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $22.15 / -0.41 (-1.82%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $22.15 / -0.41 (-1.82%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $22.15 / -0.41 (-1.82%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit
Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs 13:01 01/22/21 01/22 13:01 01/22/21 13:01 BKR Baker Hughes $21.97 / -0.59 (-2.62%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $21.97 / -0.59 (-2.62%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $21.97 / -0.59 (-2.62%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $21.97 / -0.59 (-2.62%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit

Upgrade	Icade upgraded to Buy from Hold at Deutsche Bank » 12:57 01/22/21 01/22 12:57 01/22/21 12:57 CDMGF Icade $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CDMGF Icade $0.00 / + (+0.00%) 01/19/21 Barclays Icade price target lowered to EUR 67 from EUR 68 at Barclays 11/09/20 Goldman Sachs Icade upgraded to Neutral from Sell at Goldman Sachs 10/23/20 Deutsche Bank Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank 10/20/20 BofA Icade upgraded to Buy from Neutral at BofA
Periodicals	Amazon files motion to halt union election at Alabama warehouse, Reuters says » 12:56 01/22/21 01/22 12:56 01/22/21 12:56 AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) Amazon has filed a motion… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 07:10 Today Credit Suisse Amazon.com price target raised to $3,860 from $3,750 at Credit Suisse 01/21/21 BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/21/21 Judge sides with Amazon in Parler web-hosting case, NPR says 01/21/21 Parler loses request for injunction against Amazon, Bloomberg reports 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Recommendations	Sage Group price target lowered to 500 GBp from 530 GBp at Credit Suisse » 12:55 01/22/21 01/22 12:55 01/22/21 12:55 SGPYY Sage Group $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SGPYY Sage Group $0.00 / + (+0.00%) 01/14/21 Sage Group says AgeMark moves to Sage Intacct solution 12/16/20 Sage announces Sage Partner Cloud Program in the U.S., Canada SGPYY Sage Group $0.00 / + (+0.00%) 05:24 Today Peel Hunt Sage Group initiated with a Buy at Peel Hunt 01/11/21 Canaccord Sage Group price target lowered to 680 GBp from 700 GBp at Canaccord 12/10/20 Morgan Stanley Sage Group upgraded to Equal Weight from Underweight at Morgan Stanley 11/25/20 JPMorgan Sage Group price target lowered to 560 GBp from 600 GBp at JPMorgan
Recommendations	HelloFresh price target raised to EUR 81 from EUR 65 at Credit Suisse » 12:54 01/22/21 01/22 12:54 01/22/21 12:54 HLFFF HelloFresh $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HLFFF HelloFresh $0.00 / + (+0.00%) 01/21/21 Citi Citi opens positive 'Catalyst Watch' on HelloFresh, ups target to EUR 80 01/12/21 Berenberg HelloFresh price target raised to EUR 82 from EUR 68 at Berenberg 01/06/21 Morgan Stanley HelloFresh price target raised to EUR 66 from EUR 48 at Morgan Stanley 12/18/20 Barclays HelloFresh price target raised to EUR 70 from EUR 62 at Barclays
Recommendations	Sandvik AB price target raised to SEK 240 from SEK 215 at Credit Suisse » 12:54 01/22/21 01/22 12:54 01/22/21 12:54 SDVKY Sandvik AB $0.00 / + (+0.00%) Credit Suisse analyst Max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SDVKY Sandvik AB $0.00 / + (+0.00%) 01/15/21 Sandvik AB acquires minority stake in Oqton, terms undisclosed 12/24/20 Sandvik to acquire DSI Underground for approx. EUR943M 10/09/20 Sandvik AB to divest exploration business to Drillman SDVKY Sandvik AB $0.00 / + (+0.00%) 12:42 Today JPMorgan Sandvik AB price target raised to SEK 220 from SEK 215 at JPMorgan 01/19/21 UBS Sandvik AB downgraded to Neutral from Buy at UBS 01/19/21 Jefferies Sandvik AB upgraded to Buy from Hold at Jefferies 01/13/21 Barclays Sandvik AB price target raised to SEK 230 from SEK 160 at Barclays

Hot Stocks	Vuzix trading resumes 12:53 01/22/21 01/22 12:53 01/22/21 12:53 VUZI Vuzix $10.17 / -0.715 (-6.57%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options VUZI Vuzix $10.17 / -0.715 (-6.57%) 12:48 Today Vuzix trading halted, volatility trading pause 01/11/21 Vuzix confirms joint manufacturing and supply agreement with Jade Bird 12/29/20 Vuzix receives follow-on M400 Smart Glasses order 12/22/20 Vuzix enters supply agreement with large general merchandise retailer in U.S. VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/19/21 Maxim Vuzix price target raised to $13 from $6.50 at Maxim 09/04/20 Craig-Hallum Vuzix price target raised to $8 from $6 at Craig-Hallum 05/11/20 Alliance Global Partners Vuzix downgraded to Neutral from Buy at Alliance Global Partners VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/15/21 Vuzix reports preliminary Q4 revenue $4M, consensus $3.52M 11/09/20 Vuzix reports Q3 EPS (13c), consensus (12c) 08/10/20 Vuzix reports Q2 EPS (13c), consensus (15c) VUZI Vuzix $10.17 / -0.715 (-6.57%) 12/18/20 Citron says 'no way' would be shorting Vuzix VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/19/21 Largest borrow rate increases among liquid names 01/13/21 Vuzix call volume above normal and directionally bullish 12/22/20 Vuzix call volume above normal and directionally bullish 12/18/20 Vuzix call volume above normal and directionally bullish
Recommendations	Adidas price target raised to EUR 255 from EUR 250 at Credit Suisse » 12:50 01/22/21 01/22 12:50 01/22/21 12:50 ADDYY Adidas $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly ADDYY Adidas $0.00 / + (+0.00%) 12/14/20 Adidas assessing strategic alternatives for Reebok, including potential sale 09/24/20 Kanye West demands Gap board seat before product releases 09/10/20 Kohl's launches Adidas active collection with actress Zoe Saldana ADDYY Adidas $0.00 / + (+0.00%) 01/13/21 Exane BNP Paribas Adidas upgraded to Outperform from Neutral at Exane BNP Paribas 11/16/20 Berenberg Adidas price target raised to EUR 310 from EUR 290 at Berenberg 11/13/20 RBC Capital Adidas downgraded to Sector Perform from Outperform at RBC Capital 11/11/20 Morgan Stanley Adidas price target raised to EUR 210 from EUR 195 at Morgan Stanley ADDYY Adidas $0.00 / + (+0.00%) 12/29/20 Reebok's $2.4B price tag brings new buyers to the table, Forbes reports 10/22/20 Adidas said to plan to sell Reebok business, Reuters reports ADDYY Adidas $0.00 / + (+0.00%) 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 09/22/20 Fly Intel: What to watch in Nike's earnings report
Hot Stocks	Vuzix trading halted, volatility trading pause 12:48 01/22/21 01/22 12:48 01/22/21 12:48 VUZI Vuzix $10.15 / -0.735 (-6.75%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/11/21 Vuzix confirms joint manufacturing and supply agreement with Jade Bird 12/29/20 Vuzix receives follow-on M400 Smart Glasses order 12/22/20 Vuzix enters supply agreement with large general merchandise retailer in U.S. 12/02/20 Vuzix announces follow-on order from Pixee Medical VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/19/21 Maxim Vuzix price target raised to $13 from $6.50 at Maxim 09/04/20 Craig-Hallum Vuzix price target raised to $8 from $6 at Craig-Hallum 05/11/20 Alliance Global Partners Vuzix downgraded to Neutral from Buy at Alliance Global Partners VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/15/21 Vuzix reports preliminary Q4 revenue $4M, consensus $3.52M 11/09/20 Vuzix reports Q3 EPS (13c), consensus (12c) 08/10/20 Vuzix reports Q2 EPS (13c), consensus (15c) VUZI Vuzix $10.15 / -0.735 (-6.75%) 12/18/20 Citron says 'no way' would be shorting Vuzix VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/19/21 Largest borrow rate increases among liquid names 01/13/21 Vuzix call volume above normal and directionally bullish 12/22/20 Vuzix call volume above normal and directionally bullish 12/18/20 Vuzix call volume above normal and directionally bullish
Recommendations	ProsiebenSat price target raised to EUR 16.50 at Citi » 12:48 01/22/21 01/22 12:48 01/22/21 12:48 PBSFY ProsiebenSat $0.00 / + (+0.00%) Citi analyst Catherine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PBSFY ProsiebenSat $0.00 / + (+0.00%) 12:41 Today JPMorgan ProsiebenSat price target raised to EUR 21 from EUR 19.50 at JPMorgan 01/21/21 Morgan Stanley ProsiebenSat price target raised to EUR 10 from EUR 7.50 at Morgan Stanley 01/20/21 BofA ProsiebenSat downgraded to Underperform from Neutral at BofA 01/12/21 Berenberg ProsiebenSat price target raised to EUR 14.50 from EUR 13.35 at Berenberg
Hot Stocks	GameStop trading resumes after volatility halt, shares up 52% to $65.56 12:48 01/22/21 01/22 12:48 01/22/21 12:48 GME GameStop $59.87 / +16.89 (+39.30%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $59.87 / +16.89 (+39.30%) 12:46 Today GameStop trading resumes 12:41 Today GameStop trading halted, volatility trading pause 12:00 Today GameStop rises 19.2% 01/20/21 GameStop falls -6.7% GME GameStop $59.87 / +16.89 (+39.30%) 01/13/21 Standpoint Research GameStop downgraded to Hold from Buy at Standpoint Research 01/11/21 Benchmark Benchmark 'not surprised' by GameStop board change after 'disappointing' holiday 12/09/20 Benchmark GameStop price target lowered to $5 from $6 at Benchmark 12/04/20 Wedbush GameStop price target raised to $16 from $8 at Wedbush GME GameStop $59.87 / +16.89 (+39.30%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $59.87 / +16.89 (+39.30%) 11:19 Today Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says 01/09/21 GameStop caught in vicious cycle, Barron's says GME GameStop $59.87 / +16.89 (+39.30%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store GME GameStop $59.87 / +16.89 (+39.30%) 01/19/21 Largest borrow rate increases among liquid names 01/14/21 Notable open interest changes for January 14th 01/13/21 GameStop call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names

Recommendations	Just Eat Takeaway.com price target raised to EUR 156 from EUR 146 at Citi » 12:47 01/22/21 01/22 12:47 01/22/21 12:47 TKAYY Just Eat Takeaway.com / + Citi analyst Monique… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TKAYY Just Eat Takeaway.com / + 01/14/21 Credit Suisse Just Eat Takeaway.com price target raised to 12,200 GBp at Credit Suisse 01/08/21 Morgan Stanley Just Eat Takeaway.com price target raised to 11,700 GBp at Morgan Stanley 10/16/20 HSBC HSBC upgrades Just Eat Takeaway.com to Buy on continued execution 10/16/20 HSBC Just Eat Takeaway.com upgraded to Buy from Hold at HSBC
Recommendations	LightPath price target raised to $5.50 from $4 at Alliance Global Partners » 12:47 01/22/21 01/22 12:47 01/22/21 12:47 LPTH LightPath $4.00 / -0.13 (-3.15%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events LPTH LightPath $4.00 / -0.13 (-3.15%) 01/21/21 LightPath expands factory for infrared coating capabilities in Latvia 01/15/21 LightPath announces new sales office in Germany 12/03/20 LightPath awarded $5.8M annual supply agreement renewal 11/19/20 LightPath announces Rosh Electroptics as new sales partner in israel LPTH LightPath $4.00 / -0.13 (-3.15%) 11/09/20 Alliance Global Partners LightPath initiated with a Buy at Alliance Global Partners 09/11/20 B. Riley FBR LightPath price target raised to $3.75 from $3.25 at B. Riley FBR 04/13/20 B. Riley FBR LightPath upgraded to Buy from Neutral at B. Riley FBR 02/03/21 LightPath - LPTH
Hot Stocks	GameStop trading resumes 12:46 01/22/21 01/22 12:46 01/22/21 12:46 GME GameStop $61.45 / +18.47 (+42.97%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $61.45 / +18.47 (+42.97%) 12:41 Today GameStop trading halted, volatility trading pause 12:00 Today GameStop rises 19.2% 01/20/21 GameStop falls -6.7% 01/19/21 GameStop rises 24.6% GME GameStop $61.45 / +18.47 (+42.97%) 01/13/21 Standpoint Research GameStop downgraded to Hold from Buy at Standpoint Research 01/11/21 Benchmark Benchmark 'not surprised' by GameStop board change after 'disappointing' holiday 12/09/20 Benchmark GameStop price target lowered to $5 from $6 at Benchmark 12/04/20 Wedbush GameStop price target raised to $16 from $8 at Wedbush GME GameStop $61.45 / +18.47 (+42.97%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $61.45 / +18.47 (+42.97%) 11:19 Today Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says 01/09/21 GameStop caught in vicious cycle, Barron's says GME GameStop $61.45 / +18.47 (+42.97%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store GME GameStop $61.45 / +18.47 (+42.97%) 01/19/21 Largest borrow rate increases among liquid names 01/14/21 Notable open interest changes for January 14th 01/13/21 GameStop call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names
Options	Beyond Meat call volume above normal and directionally bullish » 12:45 01/22/21 01/22 12:45 01/22/21 12:45 BYND Beyond Meat $136.00 / +1.39 (+1.03%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BYND Beyond Meat $136.00 / +1.39 (+1.03%) 01/15/21 Beyond Meat announces plans for new global headquarters 01/14/21 Taco Bell exploring new plant-based protein with Beyond Meat 11/16/20 Beyond Meat unveils next iteration of Beyond Burger for early 2021 11/10/20 Beyond Meat CEO: Really excited about launch with Pizza Hut BYND Beyond Meat $136.00 / +1.39 (+1.03%) 09:55 Today Fly Intel: Top five analyst initiations 08:15 Today Longbow Longbow starts Beyond Meat at Neutral due to multiple and near-term uncertainty 08:10 Today Longbow Beyond Meat initiated with a Neutral at Longbow 01/20/21 Fly Intel: Top five analyst downgrades BYND Beyond Meat $136.00 / +1.39 (+1.03%) 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close 08/04/20 Beyond Meat 2020 outlook remains suspended 08/04/20 Beyond Meat reports Q2 EPS (2c), consensus (4c) BYND Beyond Meat $136.00 / +1.39 (+1.03%) 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' 11/09/20 Beyond Meat says co-created 'McPlant' burger with McDonald's, Reuters reports 09/29/20 Chanos says Beyond Meat expansion at Walmart previously announced 09/22/20 Impossible Foods enters Canadian fast casual market, Techcrunch reports BYND Beyond Meat $136.00 / +1.39 (+1.03%) 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday BYND Beyond Meat $136.00 / +1.39 (+1.03%) 01/13/21 Largest borrow rate increases among liquid names 11/18/20 Unusually active option classes on open November 18th 10/06/20 Beyond Meat call volume above normal and directionally bullish 09/29/20 Beyond Meat call volume above normal and directionally bullish
General news	Week of 1/22 Baker Hughes Rig Count to be released at 13:00 12:45 01/22/21 01/22 12:45 01/22/21 12:45

General news	Week of 1/22 Baker Hughes Rig Count to be released at 13:00 12:45 01/22/21 01/22 12:45 01/22/21 12:45
Recommendations	LafargeHolcim price target lowered to CHF 57 from CHF 59 at JPMorgan » 12:43 01/22/21 01/22 12:43 01/22/21 12:43 HCMLY LafargeHolcim $0.00 / + (+0.00%) JPMorgan analyst Elodie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/20/21 Barclays LafargeHolcim price target raised to CHF 57 from CHF 54 at Barclays 01/20/21 UBS LafargeHolcim price target raised to CHF 57 from CHF 48 at UBS 01/14/21 Berenberg LafargeHolcim initiated with a Hold at Berenberg 01/08/21 JPMorgan LafargeHolcim price target raised to CHF 59 from CHF 51 at JPMorgan HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	HeidelbergCement price target lowered to EUR 68 from EUR 70 at JPMorgan » 12:43 01/22/21 01/22 12:43 01/22/21 12:43 HDELY HeidelbergCement $0.00 / + (+0.00%) JPMorgan analyst Elodie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HDELY HeidelbergCement $0.00 / + (+0.00%) 01/20/21 Barclays HeidelbergCement price target raised to EUR 74 from EUR 64 at Barclays 01/20/21 UBS HeidelbergCement price target raised to EUR 71.50 from EUR 68.50 at UBS 01/14/21 Berenberg HeidelbergCement initiated with a Buy at Berenberg 01/08/21 JPMorgan HeidelbergCement price target raised to EUR 70 from EUR 60 at JPMorgan
Recommendations	Smith & Nephew price target raised to 1,563 GBp from 1,438 GBp at JPMorgan » 12:42 01/22/21 01/22 12:42 01/22/21 12:42 SNN Smith & Nephew $45.32 / +0.425 (+0.95%) JPMorgan analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SNN Smith & Nephew $45.32 / +0.425 (+0.95%) 01/04/21 Integra LifeSciences completes sale of Extremity Orthopedics unit to Smith & Nephew 11/20/20 Smith & Nephew notes that FY20 guidance remains withdrawn 09/29/20 Integra to divest Extremity Orthopedics business to Smith & Nephew for $240M SNN Smith & Nephew $45.32 / +0.425 (+0.95%) 01/21/21 Barclays Smith & Nephew price target lowered to 1,875 GBp from 1,900 GBp at Barclays 01/21/21 Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 01/20/21 Berenberg Smith & Nephew price target raised to 2,005 GBp from 1,975 GBp at Berenberg 12/18/20 JPMorgan Smith & Nephew price target lowered to 1,438 GBp from 1,596 GBp at JPMorgan
Recommendations	Sandvik AB price target raised to SEK 220 from SEK 215 at JPMorgan » 12:42 01/22/21 01/22 12:42 01/22/21 12:42 SDVKY Sandvik AB $0.00 / + (+0.00%) JPMorgan analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SDVKY Sandvik AB $0.00 / + (+0.00%) 01/15/21 Sandvik AB acquires minority stake in Oqton, terms undisclosed 12/24/20 Sandvik to acquire DSI Underground for approx. EUR943M 10/09/20 Sandvik AB to divest exploration business to Drillman SDVKY Sandvik AB $0.00 / + (+0.00%) 01/19/21 UBS Sandvik AB downgraded to Neutral from Buy at UBS 01/19/21 Jefferies Sandvik AB upgraded to Buy from Hold at Jefferies 01/13/21 Barclays Sandvik AB price target raised to SEK 230 from SEK 160 at Barclays 01/12/21 Deutsche Bank Sandvik AB price target raised to SEK 205 from SEK 190 at Deutsche Bank

Events

Earnings calls, analyst events, roadshows and more

BIOL
Today at 14:00

Biolase Inc. Firm Sponsored Meetings

27042 Towne Centre Dr Suite 270, Foothill Ranch, CA
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
NBAC
2021-01-25 at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting
USB
2021-01-25 at 00:00

U.S. Bancorp Firm Sponsored Meetings

Virtual Meeting
SEEL
2021-01-25 at 00:00

Seelos Therapeutics Firm Sponsored Meetings

Virtual Meeting
FDX
2021-01-25 at 00:00

FedEx Firm Sponsored Meetings

Virtual Meeting
NAVB
2021-01-25 at 00:00

Navidea Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Activision Blizzard call volume above normal and directionally bullish

TODAY'S FREE FLY STORIES

Get Full Fly Access